| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/15/2013 | CN101772494B 4-pyrimidinesulfamide derivative |
| 05/15/2013 | CN101744285B Method for preparing emulsified and gelatinized functional fatty acid carrier |
| 05/15/2013 | CN101732370B Method for extracting an alpha-glucosidase active inhibitor from Limonium gmelinii(Willd.)Kuntze |
| 05/15/2013 | CN101406537B Use of Geum japonicum Thunb. var. Chinense F. Bolle extract for preparing medicament for treating obesity |
| 05/15/2013 | CN101392015B Triterpene saponin in camellia seeds, preparation method and medical use thereof |
| 05/15/2013 | CN101171927B Choline-silicic acid complex with osmolytes and divalent trace elements |
| 05/14/2013 | US8442611 Medical device with reservoir-based sensors |
| 05/14/2013 | US8440694 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptor |
| 05/14/2013 | US8440682 4-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitors |
| 05/14/2013 | US8440668 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes |
| 05/14/2013 | US8440661 Methods of modulating inflammatory cell recruitment and gene expression using haloaryl substituted aminopurines |
| 05/14/2013 | US8440644 Compounds as receptor modulators with therapeutic utility |
| 05/14/2013 | US8440621 Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels |
| 05/14/2013 | US8440615 Pharmaceutical and/or cosmetic composition containing active-principle activators of aconitase |
| 05/14/2013 | US8440183 Angiogenin complexes (ANGex) with lipid-based substrates and uses thereof |
| 05/14/2013 | US8440179 Agent for reducing visceral fat |
| 05/14/2013 | CA2568391C Coated tablet formulation and method |
| 05/14/2013 | CA2560927C Insulin resistance-improving agent |
| 05/14/2013 | CA2539193C New rarbeta receptor-activating ligand, method for the preparation ther eof and use thereof in human medicine and in cosmetics |
| 05/14/2013 | CA2514720C Coated particles and pharmaceutical dosage forms |
| 05/10/2013 | WO2013067485A1 Nutritional supplement for weight management |
| 05/10/2013 | WO2013067357A1 Peptide analogs for treating diseases and disorders |
| 05/10/2013 | WO2013066869A1 Piperidinyl-substituted lactams as gpr119 modulators |
| 05/10/2013 | WO2013065913A1 Gene therapy for diabetic neuropathy using an hgf isoform |
| 05/10/2013 | WO2013065835A1 Pharmaceutical composition for treating diabetes |
| 05/10/2013 | WO2013064669A1 Glp-1 receptor agonist peptide gastrin conjugates |
| 05/10/2013 | WO2013064465A1 New aryl-quinoline derivatives |
| 05/10/2013 | WO2013064445A1 Imidazopyridazine compounds |
| 05/10/2013 | WO2013063877A1 Glp-1 derivate dlg3312 and solid-phase chemical synthesis method thereof |
| 05/10/2013 | WO2013063849A1 Application of roseburia in treating and preventing obesity related diseases |
| 05/10/2013 | WO2013044356A9 Pharmaceutical compositions comprising phosphate binder, calcium receptor-active compound and/or active vitamin d |
| 05/10/2013 | WO2013037889A3 Vaccine |
| 05/10/2013 | WO2013028555A3 Methods for weight loss and ketogenic compositions |
| 05/10/2013 | WO2013028017A3 Composition containing silk fibroin having a high molecular weight for lowering blood sugar and cholesterol, and a method of producing same |
| 05/10/2013 | WO2013008164A3 Method of treating atherosclerosis in high triglyceride subjects |
| 05/10/2013 | WO2012178022A3 Therapeutic applications targeting sarm1 |
| 05/10/2013 | WO2012124311A8 Novel phenylpyridine derivative and drug containing same |
| 05/10/2013 | CA2854175A1 Peptide analogs for treating diseases and disorders |
| 05/10/2013 | CA2853918A1 Gene therapy for diabetic neuropathy using an hgf isoform |
| 05/10/2013 | CA2853884A1 Glp-1 receptor agonist peptide gastrin conjugates |
| 05/10/2013 | CA2849945A1 New aryl-quinoline derivatives |
| 05/10/2013 | CA2849194A1 Imidazopyridazine compounds |
| 05/09/2013 | US20130116309 Oligomeric compounds for the modulation of hif-1a expression |
| 05/09/2013 | US20130116290 Use of Dipeptidyl Peptidase IV Effectors for Normalizing the Blood Glucose Level in Mammals |
| 05/09/2013 | US20130116237 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists |
| 05/09/2013 | US20130115319 Herbal composition for lowering likelihood of stroke and methods for healing stroke patients |
| 05/09/2013 | US20130115246 Reduced dose oral pharmaceutical compositions of fenofibrate |
| 05/09/2013 | US20130115224 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 05/09/2013 | US20130115221 HIFa prolyl hydroxylation assay |
| 05/09/2013 | US20130115201 Fluid Supplement with Prenatal Vitamins |
| 05/08/2013 | EP2589601A1 Compound for inhibiting type 5 phosphodiesterase and preparation method thereof |
| 05/08/2013 | EP2589599A1 Novel hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors |
| 05/08/2013 | EP2589383A1 FKBP subtype-specific rapamycin analogue for use in treatment of diseases |
| 05/08/2013 | EP2589301A1 Ingredient reconstituted from dry fruit and/or carob |
| 05/08/2013 | EP2588458A1 Novel tetrahydroquinoline derivatives |
| 05/08/2013 | EP2588445A1 New polymorphic form of a calcimimetic compound |
| 05/08/2013 | EP2588444A1 New polymorphic form of a calcimimetic compound |
| 05/08/2013 | EP2588197A1 Fused heterocyclic compounds as ion channel modulators |
| 05/08/2013 | EP2588134A1 Diagnostic assay for type 1 diabetes |
| 05/08/2013 | EP2588113A1 A reconstituted high density lipoprotein formulation and production method thereof |
| 05/08/2013 | EP2588103A1 A combination of atorvastatin and aspirin to be used in the treatment of cardiovascular diseases |
| 05/08/2013 | EP2502939A9 Nonnatural collagen-like protein and use thereof |
| 05/08/2013 | CN103097392A Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 05/08/2013 | CN103096977A Fused heterocyclic compounds as ion channel modulators |
| 05/08/2013 | CN103096914A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases |
| 05/08/2013 | CN103096913A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases |
| 05/08/2013 | CN103096912A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases |
| 05/08/2013 | CN103096911A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases |
| 05/08/2013 | CN103096910A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl tRNA synthetases |
| 05/08/2013 | CN103096904A Mitigating agent for alcohol-induced problems |
| 05/08/2013 | CN103096892A Pharmaceutical compositions including carbamoyloxy arylalkanoyl arylpiperazine compound |
| 05/08/2013 | CN103096735A Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore |
| 05/08/2013 | CN103087180A Glucagon-like peptide 1 (GLP-1) analogues with long-acting effect and application thereof |
| 05/08/2013 | CN103087179A Long-acting glucagon-like peptide 1 (GLP-1) analogues and application thereof |
| 05/08/2013 | CN103087178A Long-acting glucagon-like peptide 1 (GLP-1) analogues and application thereof |
| 05/08/2013 | CN103087177A Long-acting glucagon-like peptide 1 (GLP-1) analogues and application thereof |
| 05/08/2013 | CN103087176A Long-acting glucagon-like peptide 1 (GLP-1) analogues and application thereof |
| 05/08/2013 | CN103087175A Novel long-acting glucagon-like peptide 1 (GLP-1) analogues and application thereof |
| 05/08/2013 | CN103087174A GLP-1 derivative DLG3312 and solid-phase chemical synthesis method thereof |
| 05/08/2013 | CN103087133A Purine derivatives as adenosine a1 receptor agonists and methods of use thereof |
| 05/08/2013 | CN103087078A Thienopyridine and furopyridine kinase inhibitors |
| 05/08/2013 | CN103087067A Compound serving as dipeptidyl enzyme inhibitor and composition thereof and applications of compound and composition |
| 05/08/2013 | CN103087066A Haloaryl Substituted Aminopurines, Compositions Thereof, And Methods Of Treatment Therewith |
| 05/08/2013 | CN103087026A Crystal form D of 7-hydroxyl isoflavone, preparation method of crystal form D and medicine composition and use of crystal form D |
| 05/08/2013 | CN103087021A Sesquiterpenes ester compound, as well as preparation method and use thereof |
| 05/08/2013 | CN103087009A Carboxylic acid derivative compound and preparation method and application thereof |
| 05/08/2013 | CN103086981A New compounds |
| 05/08/2013 | CN103086936A Aryl compounds as PPAR ligands and their use |
| 05/08/2013 | CN103086859A 2,4-dihydroxy-5,6-substituted-1-halogenobenzene derivative, synthesis method and application thereof |
| 05/08/2013 | CN103083672A DPP-IV inhibitor combined with further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation |
| 05/08/2013 | CN103083670A Application of inhibiting agent of cathepsin K |
| 05/08/2013 | CN103083669A Method for treatment of inflammatory disease and disorder |
| 05/08/2013 | CN103083668A Protein for regulating lipid metabolism and application thereof |
| 05/08/2013 | CN103083648A Troche for enhancing bone mineral density based on milk mineral salt as raw material as well as preparation method thereof |
| 05/08/2013 | CN103083593A Drug for treating qi-blood-body fluid diseases |
| 05/08/2013 | CN103083588A Medicine for losing weight |
| 05/08/2013 | CN103083582A Medicine for treating hyperlipidemia |
| 05/08/2013 | CN103083557A Traditional Chinese medicine composition with functions of reducing blood pressure and blood fat |
| 05/08/2013 | CN103083535A Dark tea composition and application in weight losing field |
| 05/08/2013 | CN103083531A Drug for treating diabetes |